Barinthus Biotherapeutics (BRNS)

Barinthus Biotherapeutics Pty Limited • Vaccitech Oncology Limited • Barinthus Biotherapeutics (UK) Limited • Barinthus Biotherapeutics North America, Inc. • Barinthus Biotherapeutics Italia S.R.L. • Barinthus Biotherapeutics Switzerland GmbH ...

BRNS stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

8-K

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

10 Jan 25

8-K

Departure of Directors or Certain Officers

25 Nov 24

8-K

Regulation FD Disclosure

6 Nov 24

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

6 Nov 24

8-K

Departure of Directors or Certain Officers

8 Aug 24

Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

Regulation FD Disclosure

6 Jun 24

Latest ownership filings

View all

Financial summary

Financial statements Chart BRNS financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	106.10 mm	106.10 mm	106.10 mm	106.10 mm	106.10 mm	106.10 mm
Cash burn (monthly)	3.89 mm	4.52 mm	3.13 mm	5.38 mm	6.07 mm	5.14 mm
Cash used (since last report)	15.68 mm	18.20 mm	12.60 mm	21.68 mm	24.45 mm	20.70 mm
Cash remaining	90.42 mm	87.90 mm	93.50 mm	84.42 mm	81.66 mm	85.40 mm
Runway (months of cash)	23.2	19.5	29.9	15.7	13.5	16.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

BRNS institutional ownership history Ownership history

17.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	10	3	+233.3%
Opened positions	7	1	+600.0%
Closed positions	0	5	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	7.43 bn	55.20 mm	+13351.2%
Total shares	6.93 mm	38.19 k	+18037.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
M&G	5.20 mm	$5.20 bn	NEW
GOOG Alphabet	1.51 mm	$2.12 bn	NEW
Johns Hopkins University	122.24 k	$171.00 k	NEW
Renaissance Technologies	25.10 k	$35.14 mm	NEW
Ipswich Investment Management	23.08 k	$32.31 mm	0.0%
Catalina Capital	17.82 k	$24.95 mm	NEW
Janney Montgomery Scott	15.01 k	$21.00 k	0.0%
Geode Capital Management	11.57 k	$16.20 mm	NEW
New England Capital Financial Advisors	104.00	$146.00 k	0.0%
Rhumbline Advisers	60.00	$84.00 k	NEW

Largest transactions	Shares	Bought/sold	Change
M&G	5.20 mm	+5.20 mm	NEW
GOOG Alphabet	1.51 mm	+1.51 mm	NEW
Johns Hopkins University	122.24 k	+122.24 k	NEW
Renaissance Technologies	25.10 k	+25.10 k	NEW
Catalina Capital	17.82 k	+17.82 k	NEW
Geode Capital Management	11.57 k	+11.57 k	NEW
Rhumbline Advisers	60.00	+60.00	NEW
Proequities	0.00	0.00
Janney Montgomery Scott	15.01 k	0.00	0.0%
Ipswich Investment Management	23.08 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BRNS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Jun 24	Leon Hooftman	Share Option Ordinary Shares	Grant	Acquire A	No	No	2	195,166	390.33 k	195,166
10 May 24	Robin Wright	Share Option Ordinary Shares	Grant	Acquire A	No	No	2.34	19,516	45.67 k	19,516